Rosiglitazone for Active Ulcerative Colitis: A Randomized Placebo-Controlled Trial

BACKGROUND: Thiazolidinedione ligands for the gamma subtype of peroxisome proliferator-activated receptors (PPARγ), widely used to treat type 2 diabetes mellitus, have been proposed as novel therapies for ulcerative colitis. METHODS: This multicenter randomized, double blind, placebo-controlled clin...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Lewis, James D., Lichtenstein, Gary R., Deren, Julius J, Sands, Bruce E., Hanauer, Stephen B., Katz, Jeffry A., Lashner, Bret, Present, Daniel H., Chuai, Shaokun, Ellenberg, Jonas H., Nessel, Lisa, Wu, Gary D.
Format: Artigo
Langue:Inglês
Publié: 2007
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2276587/
https://ncbi.nlm.nih.gov/pubmed/18325386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2007.12.012
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires